|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/04 | |
| C07K 7/08 |
| (11) | Patento numeris | 2790715 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11817532.2 |
| Europos patento paraiškos padavimo data | 2011-12-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-10-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-12-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2011/003256 |
| Data | 2011-12-13 |
| (87) | Numeris | WO 2013/088194 |
| Data | 2013-06-20 |
| (72) |
MULLER, Sylviane, FR
BRIAND, Jean-Paul, FR
ZIMMER, Robert, FR
|
| (73) |
Centre National de la Recherche Scientifique,
3, rue Michel Ange, 75794 Paris Cedex 16,
FR
ImmuPharma France SA, 5, rue du Rhōne, 68100 Mulhouse, FR |
| (54) | MODIFIED PEPTIDES AND THEIR USE FOR TREATING AUTOIMMUNE DISEASES |
| MODIFIED PEPTIDES AND THEIR USE FOR TREATING AUTOIMMUNE DISEASES |